Purpose: Seizure is a common complication after stroke. However, the clinical characteristics, treatment, and recurrence rates in patients with the first episode of post-stroke seizure remain unclarified. The aim of this study was to identify the predictors of seizure recurrence in those patients. Method: We retrospectively identified patients admitted to our hospital between July 2010 and June 2014 and followed-up until June 2015 because of the first episode of post-stroke seizure. We classified poststroke seizure as early (within one week after stroke) or late (in the second week or later). We compared the baseline clinical characteristics and treatment between the groups and investigated the factors that determined seizure recurrence by Cox proportional hazards model. Results: A total of 153 patients (84 men; mean age, 73.7 AE 12.3 years; 73 hemorrhagic and 80 ischemic strokes; 63 early and 90 late seizure) were included. Compared with the late seizure group, the early seizure group more frequently manifested with status epilepticus; tended to less often undergo stereotactic aspiration of hematoma; and less frequently used anti-epileptic drugs. During the observation period (median 364 days, IQR 124-680 days), 40 patients were lost to follow-up; subsequently, 113 patients were included in the analysis. The early seizure group had lower survival and seizure recurrence rates than the late seizure group. The factors significantly associated with seizure recurrence were presence of status epilepticus in the early group (HR 4.75, 95% CI 1.28-17.62) and younger age in the late seizure group (HR 0.95, 95% CI 0.93-0.99). Conclusions: In patients with post-stroke seizure, status epilepticus and younger age were the predictors of recurrence after early and late seizure, respectively.
Introduction
According to the epidemiologic guidelines developed by the International League Against Epilepsy [1] , first-episode seizures are divided into the acute symptomatic and unprovoked types. Acute symptomatic seizures occur in close relationship with an acute central nervous system insult, which may either be metabolic, toxic, structural, infectious, or inflammatory. Unprovoked seizures are defined as those occurring in the absence of a potentially responsible clinical condition or beyond the interval estimated for acute symptomatic seizures to occur. Unprovoked seizures differ from acute symptomatic seizures in terms of higher risk for recurrence and lower mortality rate [2] . Cerebrovascular disease is the most common cause of both acute symptomatic and unprovoked seizures in the elderly [3, 4] . Post-stroke seizures (PSS) account for 39% to 45% of all seizures in the elderly [5, 6] . According to previous reports [7] , PSS occurring within 1 or 2 weeks after stroke are classified as early seizure (ES), whereas those occurring beyond that period are classified as late seizure (LS). Hemorrhagic stroke, high NIH stroke score, and cortical lesions are most commonly associated with PSS [7] [8] [9] [10] [11] [12] . The risk factors for PSS recurrence have been reported to be late onset of seizure, stroke severity, age less than 74 years, valproic acid monotherapy, and the presence of convulsions on admission [9, 13, 14] . One report showed that young age and male gender were associated with seizure recurrence after the first post-ischemic stroke seizure [15] . Another report showed that a relatively large volume of hematoma was a predictor of seizure recurrence after the first post-hemorrhagic stroke seizure [16] . However, no reports have evaluated the risk factors for PSS recurrence after the first episode based on onset (ES vs. LS). In this hospital-based retrospective study, we sought to identify the predictors of seizure recurrence in patients with first-episode PSS based on timing of onset.
Methods

Study setting
All patients admitted to the Department of Stroke and Cerebrovascular Diseases of the National Cerebral and Cardiovascular Center (NCVC) were registered in a database (the NCVC Stroke Registry; Clinical Trials.gov: NCT02251665). The NCVC is a specialized and comprehensive cardiovascular center; data for the registry were collected systemically at the time of discharge.
We retrospectively identified patients with the first episode of PSS between July 2010 and June 2014 and who were followed-up until June 2015. We evaluated only those patients with sufficient available data from the hospitalization and outpatient records or from telephone inquiry with the patients or their relatives. Two stroke neurologists assessed the magnetic resonance imaging findings of the patients and evaluated cortical involvement. The diagnosis of PSS was made by stroke neurologists based on electroencephalogram findings and/or seizure semiology. Recurrence after the first episode of PSS was defined as readmission due to seizure. Symptoms that were not diagnosed definitely as seizure were excluded.
This study was approved by the ethics committee of the NCVC. Verbal consent for use of clinical records was taken from patients during follow-up. All data were anonymized prior to analysis. We disclosed the present study with an opt-out choice in our website.
Clinical characteristics, treatment, mortality, and seizure recurrence
We classified PSS into ES (within 1 week after stroke) and LS (in the 2nd week or later after stroke). The ES group comprised patients admitted in our hospital for stroke, after which the seizures occurred within one week. We compared the ES and LS groups in terms of baseline clinical characteristics, including age, sex, stroke type, status epilepticus, cortical involvement, cranial surgery (removal of hematoma and/or ventricular drainage in acute phase of stroke, before the first post-stroke seizure), and treatment. Status epilepticus was classified into convulsive and non-convulsive types. Convulsive status epilepticus was defined as a seizure lasting for more than 5 min or as more than one seizure episode within a 5-min period without returning to a normal state in between. Non-convulsive status epilepticus was defined as the persistent (>10 min) change in behavior and mental processes from baseline without motor symptoms [17] . The all diagnoses of non-convulsive status epilepticus required the epileptiform discharges and/or electroencephalogram findings and clinical improvement after intravenous anti-epileptic drugs (AED) [18] . History of treatment with AED was divided into two periods: acute phase (during hospitalization only) and maintenance phase (after discharge). Among patients with follow-up data, the ES and LS groups were compared in terms of rates of mortality and seizure recurrence. Seizure recurrence was defined as a seizure occurrence in the second week or later after the first episode. We investigated the factors that determined seizure recurrence in the ES and LS groups separately.
Statistical analysis
Continuous variables were presented as mean AE standard deviation or median and interquartile range (IQR). Differences in the clinical and demographic categorical variables between the ES and LS groups were evaluated by the Fisher's exact test. Mortality and seizure recurrence on the Kaplan-Meier curve were compared between the groups using the log-rank test. The predictors of seizure recurrence in each group were evaluated by the Fisher's exact test. The multivariate model included all parameters that had a p value of <0.25 on the Fisher's exact test. Cox proportional hazards regression models were used to evaluate the independent predictors of recurrence after the first episode of PSS. Results were presented as hazard ratio (HR) with 95% confidence interval (CI). All statistical tests were two-sided and p values of <0.05 were regarded as statistically significant. All statistical analyses were performed using JMP 11 (SAS Institute Inc. Cary, NC). Fig. 1 . Study design and protocol. *Due to the fact that only patients with a first seizure episode after stroke were enrolled, we excluded 153 patients with recurrent post-stroke seizure and 167 patients with non-stroke seizure. # We could not follow-up 11 ES and 29 LS patients; this resulted to 40 insufficient data.
Results
We identified 473 consecutive patients admitted to our department for seizures between July 2010 and June 2014. A total of 153 patients (84 men; mean age, 73.7 AE 12.3 years; 73 with intracerebral hemorrhage) were included in this study (Fig. 1) ; 63 patients had ES and 90 patients had LS. All patients with ES were admitted in our hospital for stroke; the seizures occurred within one week after the stroke. No patients subsequently refused to participate in the study. Comparison of the clinical characteristics and treatment between the ES and LS groups are shown in Table 1 . Status epilepticus was seen in 10 patients (15%) in the ES group and in 1 patient (1.1%) in the LS group (P < 0.05). No patient in the ES group and 12 patients (17%) in the LS group underwent cranial surgery (P < 0.05). Diazepam, phenytoin, and fosphenytoin were used as the acute phase AEDs, whereas valproic acid, phenytoin, carbamazepine, and levetiracetam were the maintenance phase AEDs. Both in the acute and maintenance phases, the use of AED was significantly less frequent in the ES group than in the LS group.
During the observation period, there were 40 patients (29 LS and 11 ES) or their family members who did not follow-up in the clinic and could not be reached by telephone. Finally, 113 patients were subject to further analysis after a median follow-up period of 364 days (IQR, 124-680 days) (Fig. 1) . The Kaplan-Meier curves for mortality and seizure recurrence rates in the ES and LS groups are shown in Fig. 2 . Ten patients (19%) in the ES group and 25 patients (41%) in the LS group had seizure recurrence; 14 patients (25%) in the ES group and 4 patients (6%) in the LS group died during the follow-up period. Among the 14 patients in the ES group who died during follow-up, 13 died within one year after seizure onset; 4 patients died from intracerebral hemorrhage (ICH) or ischemic stroke and the others died from aspiration pneumonia or congestive heart failure. The ES group had significantly higher mortality rate (p < 0.05), but less seizure recurrence rate (p < 0.05) than the LS group.
In the univariate analysis, the predictor of seizure recurrence was identified as status epilepticus in the ES group and age in the LS group (Table 2) . Variables in the model that had a P value of <0.25 on Fisher's exact test were age in the LS group and cardioembolic type, status epilepticus, and maintenance AED in the ES group. In the Cox proportional hazards model, the independent predictor of seizure recurrence was status epilepticus in the ES group (HR 3.83, 95% CI 1.25-10.45) and younger age ( 74 years) in the LS group (HR 0.95, 95% CI 0.93-0.99) ( Table 3 ).
Discussion
The main findings of this study were as follows: (1) The ES group had higher mortality rate and lower recurrence rate than the LS group; and (2) the independent predictor of seizure recurrence was status epilepticus in the ES group and younger age ( 74 years) in the LS group.
Early onset of status epilepticus after stroke was reported to be associated with high mortality [19] ; however, only 2 of the 14 patients who died had status epilepticus. Earlier reports showed the association of ES with in-hospital [20] and 30-day [2] mortality, both of which suggested stroke as the direct cause of death. In this study, mortality in some patients was due to complications of stroke, such as pneumonia or heart failure.
We showed that the LS group had more seizure recurrence than the ES group. Several reports suggested LS as a predictor of PSS recurrence [11, 21, 22] . Since irreversible brain damage after stroke results in epileptogenesis and is the underlying mechanism of LS [23] , seizure recurrence may be more frequent in LS than in ES.
Multivariate Cox proportional hazards model demonstrated that status epilepticus was a predictor of early-onset PSS recurrence. In this study, patients with early onset of PSS developed status epilepticus more frequently than those with late onset PSS. Earlier studies reported that the rate of status epilepticus was 9% to 19% in PSS and 27% when the onset was early [19, 24] . Based on our results, the rate of status epilepticus in the ES group was 15% and that in the LS group was 1.1%. ES occurs secondary to enhanced electric irritability by excitotoxic neurotransmitters, whereas LS may originate from epileptogenic gliotic scarring [13] . Dysfunction of the blood brain barrier and brain edema usually reach their peak within 3 to 5 days after stroke [25] ; the propensity of the damaged brain region to neuronal excitation during this time might explain the more frequent status epilepticus in patients with ES than in those with LS. Velioglu et al. reported that early onset seizure was associated with a higher risk for recurrent status epilepticus than late onset seizure [19] . Because status epilepticus causes neuronal loss and reactive gliosis [26] , the damage it causes the brain, in addition to the acute stroke itself, may result in seizure recurrence following epileptogenesis in ES.
In this study, younger age was a predictor of late onset PSS recurrence, consistent with several previous reports [14, 15, 20, 27] . It was suggested that compared with the elderly, younger patients were more likely to develop large cortical infarcts, rather than small vessel disease [27] , and needed a higher dose of AED because of better drug clearance [28] . In the present study, the LS group underwent cranial surgery for ICH more frequently than the ES group. The rate of ES after ICH has been reported to range from 5% to 14% [29] [30] [31] , whereas that of LS ranged from 8% to 10% [9, 32] . Although there was no significant difference between the rates of ES and LS after ICH, a large ICH volume was reported to be a predictor of LS occurrence [33, 34] . Hemosiderin deposits have been discussed repeatedly as potential epileptogenic triggers in patients with focal epilepsy due to ICH [34] . Moreover, a gliotic scar, which comprise glial and immune cells, may contribute to persistent neuronal excitability and LS onset [35] . A large ICH volume results in a considerable amount of hemosiderin deposits and a large gliotic scar; these conditions can substantially affect LS onset. The patients who underwent surgery in this study might have a large ICH volume, and this background originally contributed to LS occurrence. Since no multivariable analysis on the association between surgery and LS was done, surgery as a risk factor for LS remained unclear. Further examinations are needed to clarify the association between younger age and seizure recurrence in LS. This study had several limitations. First, 40 patients could not be followed-up. Especially, the patient dropout was relatively large in the LS group (29/90 = 32%), which might bias the survival curve because patients with recurring seizures tended to have longer follow-up. Second, the diagnosis of seizure recurrence was based on patients' records and was not confirmed by the study physicians. Third, we could not evaluate the kinds of maintenance phase AEDs between patients with and without recurrence in the ES and LS groups.
Conclusions
In patients with a first episode of PSS, late onset of seizure significantly increased the rate of recurrence when compared to early onset seizure. The independent predictors of seizure recurrence after the first episode of PSS were status epilepticus for ES and young age for LS.
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